Pharma-clinical-trial-programs have resisted adopting BI due to its inability to satisfy regulations; including security, audit-trails and communication between companies. While not commonly seen in clinical trials, pharma companies have benefited from utilizing BI. For example, Astra Zeneca uses BI to generate immediate responses to report inquiries, while Roch’s Spain Division uses BI to generate and send individualized information to each division. Both companies increased sales since incorporating BI solutions into their decision-making process. Pharma companies can benefit from using BI in clinical trials to create Clinical Research Intelligence frameworks to enhance data collection, analysis, reporting, and dissemination to participants in other locations.